Literature DB >> 1891170

Nasopharyngeal carcinoma and lymphoinfiltration.

Y S Zong1, H Lin, D T Choy, J S Sham, W Wei, K H Chan, M H Ng.   

Abstract

Originally referred to as 'lymphoepithelioma', undifferentiated and poorly differentiated nasopharyngeal carcinoma (NPC) tissues showed intense lymphoinfiltration. In a study of cryosections from 15 NPC tissues, we found that infiltrating lymphoid elements were comprised predominantly of lymphocytes, but plasma cells, follicular dendritic cells, and eosinophils were also commonly seen. Subpopulations of lymphocytes having the same phenotypes tend to aggregate, forming clusters or secondary follicles in stromatous tissues. The tumor areas were mainly infiltrated by T cells. Tumor cells and/or apparently normal epithelium in the paratumorous areas frequently expressed CD21, CD23, CD40 and a B lymphocytes carcinoma cross-reacting antigen (BLCa), all of which are involved in B cell activation and proliferation. CD21 and BLCa were strongly expressed near the surface of both squamous and columnar epithelium by those epithelial cells which are at advanced stage of differentiation, while CD40 was expressed by epithelial cells at earlier stages of differentiation located at or near the basement membrane. CD23 was mainly expressed by columnar cells and basal cells underlying squamous epithelium, but not, or weakly so, by flattened squamous cells or reserve cells underlying columnar epithelium. The large majority of tumor cells expressed CD40 and BLCa. A substantial proportion of them also expressed CD23, but the tumor cells were not reactive for CD21. Despite eosinophilic infiltration, IL-6 was not detected in tumor tissues. IL-1 was, however, detected in abundance in the cytoplasm of follicular dendritic-like cells and in the intercellular spaces in tumor areas and surrounding stromatous tissues. The immunobiology of NPC is discussed in the light of these observations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1891170     DOI: 10.1159/000226945

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  10 in total

1.  Enhancing antitumor efficacy of chimeric antigen receptor T cells through constitutive CD40L expression.

Authors:  Kevin J Curran; Beatrijs A Seinstra; Yan Nikhamin; Raymond Yeh; Yelena Usachenko; Dayenne G van Leeuwen; Terence Purdon; Hollie J Pegram; Renier J Brentjens
Journal:  Mol Ther       Date:  2015-01-13       Impact factor: 11.454

2.  Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells.

Authors:  A Agathanggelou; G Niedobitek; R Chen; J Nicholls; W Yin; L S Young
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

Review 3.  Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein-Barr Virus-Associated Malignancies.

Authors:  Xueyi Zheng; Yuhua Huang; Kai Li; Rongzhen Luo; Muyan Cai; Jingping Yun
Journal:  Viruses       Date:  2022-05-10       Impact factor: 5.818

4.  Primary and malignant cholangiocytes undergo CD40 mediated Fas dependent apoptosis, but are insensitive to direct activation with exogenous Fas ligand.

Authors:  Elizabeth H Humphreys; Kevin T Williams; David H Adams; Simon C Afford
Journal:  PLoS One       Date:  2010-11-17       Impact factor: 3.240

5.  CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma.

Authors:  J Pammer; A Plettenberg; W Weninger; B Diller; M Mildner; A Uthman; W Issing; M Stürzl; E Tschachler
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

6.  Lymphocyte deficiency limits Epstein-Barr virus latent membrane protein 1 induced chronic inflammation and carcinogenic pathology in vivo.

Authors:  Adele Hannigan; Asif M Qureshi; Colin Nixon; Penelope M Tsimbouri; Sarah Jones; Adrian W Philbey; Joanna B Wilson
Journal:  Mol Cancer       Date:  2011-02-03       Impact factor: 27.401

7.  N-acetylcysteine (NAC) ameliorates Epstein-Barr virus latent membrane protein 1 induced chronic inflammation.

Authors:  Xiao Gao; Eirini-Maria Lampraki; Sarwah Al-Khalidi; Muhammad Asif Qureshi; Rhea Desai; Joanna Beatrice Wilson
Journal:  PLoS One       Date:  2017-12-11       Impact factor: 3.240

Review 8.  The Microenvironment in Epstein-Barr Virus-Associated Malignancies.

Authors:  Geok Wee Tan; Lydia Visser; Lu Ping Tan; Anke van den Berg; Arjan Diepstra
Journal:  Pathogens       Date:  2018-04-13

9.  Method for the validation of immunohistochemical staining using SCID mouse xenografts: expression of CD40 and CD154 in human non-small cell lung cancer.

Authors:  Keidai Ishikawa; Masaki Miyamoto; Tatsuya Yoshioka; Masatoshi Kadoya; Li Li; Roshan Mishra; Kazuomi Ichinokawa; Yasuhito Shoji; Yoshiyuki Matsumura; Yasuhiro Hida; Kichizo Kaga; Tatsuya Kato; Mitsuhito Kaji; Toshiro Ohbuchi; Tomoo Itoh; Hirotoshi Dosaka-Akita; Yoshiro Matsui; Satoshi Hirano
Journal:  Oncol Rep       Date:  2013-02-05       Impact factor: 3.906

10.  Infiltrating lymphocytes and accessory cells in nasopharyngeal carcinoma.

Authors:  Y S Zong; C Q Zhang; F Zhang; J B Ruan; M Y Chen; K T Feng; Z F Yu
Journal:  Jpn J Cancer Res       Date:  1993-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.